BAY.MI - Bayer Aktiengesellschaft

Milan - Milan Delayed price. Currency in EUR
117.50
-0.80 (-0.68%)
At close: 3:59PM CEST
Stock chart is not supported by your current browser
Previous close118.30
Open118.60
Bid0.00 x 0
Ask120.10 x 0
Day's range117.50 - 118.60
52-week range86.10 - 123.80
Volume882
Avg. volume986
Market cap97.59B
BetaN/A
PE ratio (TTM)20.33
EPS (TTM)N/A
Earnings dateN/A
Forward Dividend & YieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • The Zacks Analyst Blog Highlights: Bayer Aktiengesellschaft, Monsanto, Adaptimmune Therapeutics and Celgene
    Zacks3 days ago

    The Zacks Analyst Blog Highlights: Bayer Aktiengesellschaft, Monsanto, Adaptimmune Therapeutics and Celgene

    The Zacks Analyst Blog Highlights: Bayer Aktiengesellschaft, Monsanto, Adaptimmune Therapeutics and Celgene

  • Bayer to Sell Select Business Lines to Close Monsanto Buyout
    Zacks4 days ago

    Bayer to Sell Select Business Lines to Close Monsanto Buyout

    Bayer Aktiengesellschaft (BAYRY) inked a deal to sell selected Crop Science businesses to BASF for EUR 5.9 billion to as a part of its strategy to complete the planned acquisition of Monsanto Co.

  • The Wall Street Journal7 days ago

    [$$] Bayer to Sell Assets to BASF for $7 Billion Amid Scrutiny of Monsanto Megadeal

    Bayer said it has agreed to sell parts of its crop-science business to rival BASF, a bid to assuage regulators as the German chemical conglomerate seeks approval for its $57 billion acquisition of U.S. ...

  • Reuters - UK Focus7 days ago

    European shares climb to four-month high, boosted by Bayer

    European shares hit their highest in nearly four months on Friday, helped by gains in Bayer, after the German drugmaker sold assets that will pave the way for its acquisition of Monsanto. The pan-European ...

  • Bayer sells crop science units to ease Monsanto takeover
    AFP7 days ago

    Bayer sells crop science units to ease Monsanto takeover

    Bayer is selling off parts of its business to ease concerns of regulators about the impact of its purchase of US rival Monsanto.

  • BASF to harvest seeds, herbicide businesses from Bayer for $7 billion
    Reuters7 days ago

    BASF to harvest seeds, herbicide businesses from Bayer for $7 billion

    BASF (BASFn.DE) has agreed to buy seed and herbicide businesses from Bayer (BAYGn.DE) for 5.9 billion euros (5.26 billion pounds)in cash, as Bayer tries to convince competition authorities to approve its planned acquisition of Monsanto (MON.N). BASF, the world's third-largest maker of crop chemicals, has so far avoided seed assets and instead pursued research into plant characteristics such as drought tolerance, which it sells or licenses out to seed developers.

  • BASF Pays for Sitting Out the Chemicals Dance Party
    Bloomberg7 days ago

    BASF Pays for Sitting Out the Chemicals Dance Party

    Bayer's buyer hasn't exactly overpaid, but this is no bargain.

  • Reuters7 days ago

    Bayer's gains help European shares hit four-month high

    European shares hit their highest in nearly four months on Friday, helped by gains in Bayer (BAYGn.DE) after an asset sale deal paving the way for the German drugmaker's $66 billion acquisition of Monsanto (MON.N). The pan-European STOXX 600 (.STOXX) rose 0.3 percent, also underpinned by strength among materials stocks. Germany's DAX (.GDAXI) index was flat, just below the all-time high hit in the previous session, while Britain's FTSE (.FTSE) eased back 0.3 percent after a record close on Thursday.

  • MarketWatch7 days ago

    Germany’s stock market logs another record as Bayer rises on deal news

    European stocks mostly rise on Friday, as Bayer AG shares rally on news the German conglomerate has reached a multibillion-euro deal to sell parts of its business, which helped the DAX register another ...

  • Bayer sells units to be able to complete Monsanto takeover
    Associated Press7 days ago

    Bayer sells units to be able to complete Monsanto takeover

    BERLIN (AP) — German pharmaceutical giant Bayer AG has reached a 5.9 billion euro ($7 billion) deal to sell parts of its Crop Science unit to German chemical company BASF to alleviate regulatory concerns over its planned takeover of U.S. seed and weed-killer company Monsanto Co.

  • BASF Enters Seeds Market as Bayer Sells $7 Billion in Assets
    Bloomberg7 days ago

    BASF Enters Seeds Market as Bayer Sells $7 Billion in Assets

    BASF SE agreed to buy part of Bayer AG’s agricultural products business for 5.9 billion euros ($7 billion), seizing the opportunity to enter the genetically-modified seeds market as Bayer sells assets ...

  • BASF Enters Seeds Market as Bayer Sells $7 Billion in Assets
    Bloomberg7 days ago

    BASF Enters Seeds Market as Bayer Sells $7 Billion in Assets

    BASF SE agreed to buy part of Bayer AG’s agricultural products business for 5.9 billion euros ($7 billion), seizing the opportunity to enter the genetically-modified seeds market as Bayer sells assets ...

  • 4 Large-Cap Drug Stocks to Buy on Solid Momentum Ahead of Q3
    Zacks15 days ago

    4 Large-Cap Drug Stocks to Buy on Solid Momentum Ahead of Q3

    The Large Cap Pharmaceuticals industry has gained 20.7% year to date, outpacing 14.7% gain for the S&P 500.

  • EU pauses inquiry into Bayer-Monsanto takeover
    AFP15 days ago

    EU pauses inquiry into Bayer-Monsanto takeover

    The clock is stopped until Bayer and Monsanto give Brussels more info

  • The Wall Street Journal15 days ago

    [$$] Monsanto Boosted by Continued Adoption of New Products

    Continued adoption of new soybean, cotton and corn products drove Monsanto’s quarterly revenue, even amid what it called a challenging agricultural environment.

  • Reuters16 days ago

    Brazil agency says Bayer-Monsanto tie-up can hurt competition, urges conditions

    A unit of Brazil's competition regulator Cade has said Bayer AG's (BAYGn.DE) proposed takeover of Monsanto Co. (MON.N) could be detrimental to competition and urged conditions for Brazilian approval of the corporate tie-up, a document released on the agency's website shows. It recommended what it termed as "structural solutions" as a condition for final approval the deal, which will be in the hands of Cade's seven-member tribunal. The Cade unit said solutions included creating or strengthening another player to compete in the markets for soy and cotton seeds and in the sphere of biotech development.

  • Reuters16 days ago

    Monsanto fourth-quarter profit up as corn, soy seed sales jump

    U.S. seeds and agrochemicals company Monsanto Co, which is being acquired by Bayer AG, reported a quarterly profit on Wednesday, compared with a year-ago loss, as seed licensing deals in the typically low-revenue fourth quarter lifted sales. Monsanto shares were up slightly at $119.88 after earlier touching a more-than-two-year high. Sales of corn seeds and traits, Monsanto's biggest segment by revenue, rose nearly 16 percent while soybean seeds and traits sales climbed 22 percent in the quarter ended Aug. 31.

  • Monsanto (MON) Tops Q4 Earnings, Bayer's Buyout Deal on Track
    Zacks16 days ago

    Monsanto (MON) Tops Q4 Earnings, Bayer's Buyout Deal on Track

    Monsanto (MON) reports better-than-anticipated fourth-quarter fiscal 2017 results, estimates to close Bayer's buyout deal by end of calendar year 2017.

  • Reuters - UK Focus25 days ago

    European shares stay near highs as Merkel hangs on to power

    European shares rose slightly on Monday after German Chancellor Angela Merkel secured a fourth term but saw her party weakened by a surge in support for the far-right. Investors said the likelihood of ...

  • Bayer to end non-US sales of Essure, a contested sterilisation implant
    AFPlast month

    Bayer to end non-US sales of Essure, a contested sterilisation implant

    "Bayer will continue to market the Essure medical device in the United States, where the FDA recently assessed this device and concluded that the method had a favourable ...

  • EU opens probe into Bayer takeover of Monsanto
    AFP2 months ago

    EU opens probe into Bayer takeover of Monsanto

    The European Commission said that it was opening an in-depth investigation into the proposed $66 billion (56-billion-euro) takeover of US seed and pesticide supplier Monsanto by Germany's Bayer

  • Bayer slashes forecast after profits slide in Q2
    AFP3 months ago

    Bayer slashes forecast after profits slide in Q2

    Werner Baumann, CEO of German chemical and pharmaceuticals group Bayer, attends a press conference at the company's headquarters in Leverkusen

  • EQS Group3 months ago

    MorphoSys Announces That Its Partner Bayer Reports On Phase 2 Study of Investigational Anetumab Ravtansine in Second-Line Mesothelioma (news with additional features)

    DGAP-News: MorphoSys AG / Key word(s): Miscellaneous21.07.2017 / 18:05 The issuer is solely responsible for the content of this announcement.

  • Reuters - UK Focus4 months ago

    European shares set for biggest monthly loss in a year

    European shares were choppy on Friday and were set to end June with their biggest monthly loss in a year as worries over tightening monetary conditions soured the mood. The pan-European STOXX 600 index ...

  • Reuters - UK Focus4 months ago

    Field studies fuel dispute over whether banned pesticides harm bees

    Two major studies into how bees are affected by a group of pesticides banned in Europe gave mixed results on Thursday, fuelling a row over whether the chemicals, called neonicotinoids, are safe. The studies, one conducted across three European countries and another in Canada, found some negative effects after exposure to neonicotinoids in wild and honeybee populations, but also some positives, depending on the environmental context. Scientists who conducted the European research - in Britain, Hungary and Germany - told reporters their overall findings suggested neonicotinoids are harmful to honeybee and wild bee populations and are "a cause for concern".

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes